NEW YORK (GenomeWeb) – Alere today filed its financial results for the third quarter of 2016, reporting a 4 percent decrease in revenues year over year.

The filing puts the firm back on track with the timing of quarterly earnings reports filed with the US Securities and Exchange Commission. But Alere's results missed analyst revenue and EPS forecasts and its shares tumbled 13 percent in early afternoon trading on the New York Stock Exchange.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.